Page 54 - Read Online

Yang et al. Hepatoma Res 2020;6:37 I http://dx.doi.org/10.20517/2394-5079.2020.09 Page 11 of 13

34. de’Angelis N, Abdalla S, Lizzi V, Esposito F, Genova P, et al. Incidence and predictors of portal and splenic vein thrombosis after pure
laparoscopic splenectomy. Surgery 2017;162:1219-30.
35. Eyraud D, Granger B, Ionescu C, Fratea S, Darnat S, et al. Thrombocytopenia, splenomegaly, and portal blood flow in patients who have
undergone liver transplantation for cirrhosis. Liver Transpl 2012;18:340-6.
36. Guan YS, Hu Y. Clinical application of partial splenic embolization. Sci World J 2014;2014:961345.
37. Kheradpir MH. Partial splenectomy and partial splenic attachment for the treatment of portal hypertension. Z Kinderchir 1990;45:98-9.
38. Sretenovic A, Perisic V, Vujovic D, Opacic D, Vukadinovic V, et al. Warren shunt combined with partial splenectomy in children with
extra-hepatic portal hypertension, massive splenomegaly and severe hypersplenism. Srp Arh Celok Lek 2014;142:419-23.
39. Zhe C, Jian-Wei L, Jian C, Yu-dong F, Ping B, et al. Laparoscopic versus open splenectomy and esophagogastric devascularization for
bleeding varices or severe hypersplenism: a comparative study. J Gastrointest Surg 2013;17:654-9.
40. Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, et al. Portal vein thrombosis, mortality and hepatic decompensation in
patients with cirrhosis: a meta-analysis. World J Hepatol 2015;7:2774-80.
41. Jiang GQ, Xia BL, Chen P, Qian JJ, Jin SJ, et al. Anticoagulation therapy with warfarin versus low-dose aspirin prevents portal vein
thrombosis after laparoscopic splenectomy and azygoportal disconnection. J Laparoendosc Adv Surg Tech A 2016;26:517-23.
42. Vecchio R, Cacciola E, Cacciola RR, Marchese S, Intagliata E. Portal vein thrombosis after laparoscopic and open splenectomy. J
Laparoendosc Adv Surg Tech A 2011;21:71-5.
43. Leonardi F, Maria N, Villa E. Anticoagulation in cirrhosis: a new paradigm? Clin Mol Hepatol 2017;23:13-21.
44. Monroe DM, Hoffman M. The coagulation cascade in cirrhosis. Clin Liver Dis 2009;13:1-9.
45. Primignani M, Tosetti G, La Mura V. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol
2015;7:2906-12.
46. Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, et al. An imbalance of pro- vs anti-coagulation factors in plasma from
patients with cirrhosis. Gastroenterology 2009;137:2105-11.
47. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM. Evidence that low protein C contributes to the procoagulant
imbalance in cirrhosis. J Hepatol 2013;59:265-70.
48. Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J
Med Sci 2013;346:38-44.
49. Rodriguez-Leal GA, Moran S, Corona-Cedillo R, Brom-Valladares R. Portal vein thrombosis with protein C-S deficiency in a non-
cirrhotic patient. World J Hepatol 2014;6:532-7.
50. Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, et al. Impact of antithrombin III concentrates on portal vein thrombosis after
splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010;251:76-83.
51. Kawanaka H, Akahoshi T, Itoh S, Iguchi T, Harimoto N, et al. Optimizing risk stratification in portal vein thrombosis after splenectomy
and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension. J Am
Coll Surg 2014;219:865-74.
52. Han J, Yi Y, Ding H, Liu J, Zhang Y, et al. Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial
devascularization for portal hypertension. Zhonghua Gan Zang Bing Za Zhi 2014;22:739-43. (in Chinese)
53. Zhang Y, Wen TF, Yan LN, Yang HJ, Deng XF, et al. Preoperative predictors of portal vein thrombosis after splenectomy with
periesophagogastric devascularization. World J Gastroenterol 2012;18:1834-9.
54. Rossetto V, Spiezia L, Senzolo M, Rodriguez-Castro KI, Gavasso S, et al. Does decreased fibrinolysis have a role to play in the
development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? Intern Emerg Med 2014;9:397-403.
55. Smalberg JH, Koehler E, Darwish Murad S, Plessier A, Seijo S, et al. European Network for Vascular Disorders of the L. Fibrinogen
gamma’ and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis. Thromb Haemost 2013;109:558-60.
56. Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, et al. Portal vein thrombosis in liver cirrhosis. World J Hepatol 2014;6:64-
71.
57. Qi X, Su C, Ren W, Yang M, Jia J, et al. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic
review of the literature. Clin Res Hepatol Gastroenterol 2015;39:683-91.
58. Zhang N, Yao Y, Xue W, Wu S. Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: a systematic
review and meta-analysis. Biomed Rep 2016;5:483-90.
59. Huang D, Tao M, Cao L, Wang X, Zheng S, et al. Risk factors and anticoagulation effects of portal vein system thrombosis after
laparoscopic splenectomy in patients with or without cirrhosis. Surg Laparosc Endosc Percutan Tech 2019;29:498-502.
60. Nadinskaia MY, Kodzoeva KB, Ulyanova KA, Volkova AS, Rogacheva SI, et al. Risk factors associated with portal vein thrombosis in
liver cirrhosis: a case-control study. Ter Arkh 2019;91:73-81.
61. Hernandez Conde M, Llop Herrera E, de la Revilla Negro J, Pons Renedo F, Fernandez Puga N, et al. Prevalence and outcome of portal
thrombosis in a cohort of cirrhotic patients undergoing liver transplantation. Rev Esp Enferm Dig 2016;108:716-20.
62. Tarzamni MK, Somi MH, Farhang S, Jalilvand M. Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients.
World J Gastroenterol 2008;14:1898-902.
63. Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol 2015;5:22-40.
64. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012;57:203-12.
65. Machado NO, Chopra PJ, Sankhla D. Portal vein thrombosis postlaparoscopic splenectomy presenting with infarction of gut: review of
risk factors, investigations, postoperative surveillance, and management. Surg Laparosc Endosc Percutan Tech 2010;20:273-7.
66. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, et al. Aetiology and clinical significance of thrombocytosis: analysis